Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пьер Фабр МедикаментfiledCriticalПьер Фабр Медикамент
Priority claimed from PCT/EP2009/058709external-prioritypatent/WO2010003992A1/en
Publication of UA104144C2publicationCriticalpatent/UA104144C2/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
The invention also relates to a composition comprising an antibody antagonist to c-Met and an aminoheteroaryl compound, particularly as a medicament. The present invention also comprises a pharmaceutical composition comprising said anti c-Met antibody and said aminoheteroaryl compound as combination products for simultaneous, separate or sequential use. The invention relates to the use of the composition of the invention for the treatment of cancer in a mammal.
UAA201101377A2008-07-082009-07-08Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer
UA104144C2
(en)
Substituted 1-indole compound for use in the treatment of a disease or condition, a pharmaceutical composition comprising the compound and use of the compound for the preparation of a medicament
Compounds derived from substituted carboxyamide heterocycles, ar antagonist; pharmaceutical composition comprising them; and use in the treatment of prostate cancer.
COMPOUNDS DERIVED FROM PHENYL- (4-PHENYL PYRIMIDIN-2-IL) -AMINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; AND ITS USE IN INFLAMMATORY DISEASES, DIABETES AND CANCER.